Lior Z. Braunstein MD 1, Andrzej Niemierko PhD 2, Mina N. Shenouda MD 2, Linh Truong 3, Betro T. Sadek MD 2, Rita Abi Raad MD 2, Julia S. Wong MD 3, Rinaa.

Slides:

Advertisements

Similar presentations

Serena T. Wong, MD Assistant Professor of Medicine

Advertisements

Baptist Health System General Surgery Residency Program

Ismail Jatoi, MD, PhD, FACS Dale H. Dorn Chair in Surgery Professor and Chief, Division of Surgical Oncology University of Texas Health Science Center.

Kevin S. Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Associate Professor of Surgery Harvard.

Young and Strong The Program for Young Women with Breast Cancer at Dana-Farber Cancer Institute: Current Status and Future Plans Kim Sprunck-Harrild, MSW,

IMPACT OF TUMOR MORCELLATION ON THE NATURAL HISTORY OF UTERINE LEIOMYOSARCOMA César Serrano, Titilope Oduyebo, Judith Manola, Yang Feng, Michael G. Muto,

Isabelle Bedrosian, MD Associate Professor

Commission on Cancer Update for Massachusetts Cancer Liaison Physicians Massachusetts Chapter American College Surgeons Peter Hopewood MD FACS.

Clinical Perspective. Screening/Prevention Who is at risk for what type Decision to Intervene: Risk Assessment normal Evidence of Disease Disability Death.

Geonomics in Breast Cancer Decoding Human Genome Luis Barreras, M.D., FACP.

Breast Cancer: Follow up and Management of recurrence Carol Marquez, M.D. Associate Professor Department of Radiation Medicine OHSU.

BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.

Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)

Hypofractionated Radiation Therapy for Early Stage Breast Cancer Patrick J. Gagnon, M.D. Resident, PGY-4 Radiation Medicine, OHSU Providence Hospital Breast.

Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.

Breast conservation in Locally advanced breast cancer Department of Endocrine Surgery College of Medicine Amrita Institute of Medical Sciences Kochi, Kerala.

Driving the Transition to Individualized Cancer Treatment by Addressing Critical Questions 1 Do I need surgery? chemotherapy? radiation? INVASIVE BREAST.

New York University Department of Radiation Oncology A Phase I-II Study of Adjuvant Concurrent Carboplatin and Accelerated Radiotherapy for Triple Negative.

Suggested guidelines for appropriate patient selection for patients undergoing Accelerated Partial Breast Irradiation at DMC. Tonya Echols Cole, MD.

Ethnic Disparities in Early Breast Cancer Management among Asian Americans and Pacific Islanders Rebecca P. Gelber, MD, MPH Department of Medicine, University.

Dosimetric Comparison based on Consensus Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer Akila.

1 The Cancer Consortium Deborah Schrag, MD (PI) Caprice Christian Greenberg, MD, MPH Brigham and Women’s Hospital Dana-Farber Cancer Institute.

Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-year Single Institution Experience Benjamin Farnia, B.A. ASTRO Poster Discussion September.

The Role of Ultrasound of the Regional Nodal Basins in Staging Patients with Triple Negative Breast Cancer: Implications for Local-Regional Treatment Simona.

Radiation Breast Oncology Highlights of SABC 2006 Alison Bevan, MD PhD UCSF Radiation Oncology January, 2007.

Postoperative Radiotherapy for Patients with Stage II or III Nonsmall Cell Lung Cancer treated with Sublobar Resections: A SEER Registry Analysis Scott.

Randomized Comparison of Adjuvant Aromatase Inhibitor Exemestane plus Ovarian Function Suppression vs Tamoxifen plus Ovarian Function Suppression in Premenopausal.

HER2 POSITIVE BREAST CARCINOMA IN THE PRE AND POST ADJUVANT ANTI-HER-2 THERAPY ERA: A SINGLE ACADEMIC INSTITUTION EXPERIENCE IN THE SETTING OUTSIDE OF.

Prognostic value of ER, PR, and HER2 breast cancer biomarkers and AJCC’s TNM staging system on overall survival of Caucasian females with breast cancer.

Breast cancer in elderly patients (70 years and older): The University of Tennessee Medical Center at Knoxville 10 year experience Curzon M, Curzon C,

1 ASCO Annual Meeting 2013 Poster presentation January 2013.

Phase 2 study of the mTOR inhibitor RAD001 (everolimus) in combination with bevacizumab (avastin) in patients with sporadic and neurofibromatosis type.

Evidence for a Survival Benefit Conferred by Adjuvant Radiotherapy in a Cohort of 608 Women with Early-stage Endometrial Cancer O. Kenneth Macdonald 1,

Metabolomics Profiles Suggest a Mechanism for Caloric Restriction Induced Radiation Sensitivity Kamila Nowak, MD, T. Dan, MD, C. Guha, MD, BA Simone, DO,

NCDB Report on Breast Cancer at Sibley Cancer Committee Feb Cancer Liaison Physician Karen Lisa Smith MD MPH.

Outside Imaging in Emergency Department Transfers Jonathan Opraseuth MD Stephen Ledbetter MD MPH Aaron Sodickson MD PhD Emergency Radiology, Brigham and.

Florida Cancer Plan Phil Roland, MD FACS FACOG Florida State Chair A Commission on Cancer.

Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Outcome of Salvage Total Laryngectomy Following Organ.

Linking Electronic Health Records Across Institutions to Understand Why Women Seek Care at Multiple Sites for Breast Cancer Caroline A. Thompson, PhD,

The impact of age on outcome in early-stage breast cancer 방사선종양학과 R2. 최진현.

Patterns of care and comparative effectiveness of endocrine therapy for premenopausal women with early breast cancer A multi-institution cohort study February.

Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Harvard Medical School Date 06/01/2007.

Improving End-of-Life Care in Cancer: The Case for Video Decision Aids Angelo Volandes, MD, MPH Massachusetts General Hospital Harvard Medical School.

Risk Stratification in Stage II Colon Cancer Patients Ramzi Amri, MD, PhD; Liliana G Bordeianou, MD, MPH; and David L Berger, MD Massachusetts General.

DEPT OF RADIATION ONCOLOGY Prognostic Value of Post-Radiotherapy FDG PET in Head and Neck Cancer after Intensity Modulated Radiation Treatment Heming Lu.

Dana Farber/Harvard Cancer Center Breast Cancer Advocate Group

The Department of Biochemistry & Molecular Biology

The impact of ipsilateral breast tumor recurrence on cause specific survival in DCIS patients treated with breast conserving therapy or mastectomy C.

The POSITIVE study A large international research effort coordinated by International Breast Cancer Study Group (IBCSG) worldwide ALLIANCE for Clinical.

#BlackHealthMatters: Improving Breast Cancer Outcomes for Black Women

Figure 1 Overall survival and cause-specific survival after breast conservation treatment with radiation for 1003 patients with mammographically detected.

سرطان الثدي Breast Cancer

“Knowledge is the Best Defense Against Prostate Cancer”

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis Matthew Koshy, MD, Renuka Malik,

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Timing of Local and Distant Failure in Resected Lung Cancer: Implications for Reported Rates of Local Failure Jessamy A. Boyd, MD, Jessica L. Hubbs,

NRG Oncology Biospecimen Bank Report NRG Semiannual meeting

Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer Anthony W.

Variations in Receipt of Curative-Intent Surgery for Early-Stage Non–Small Cell Lung Cancer (NSCLC) by State Helmneh M. Sineshaw, MD, MPH, Xiao-Cheng.

Pattern of Failure Analysis in Metastatic EGFR-Mutant Lung Cancer Treated with Tyrosine Kinase Inhibitors to Identify Candidates for Consolidation Stereotactic.

Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed Emanuela Taioli, MD, PhD, Raja Flores, MD

Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey Daniel Morgensztern, MD, Shean Huey Ng,

Immune-Modulating Vaccines in Non-small Cell Lung Cancer

Predictors of Surgery and Consult with an Oncologist for Adjuvant Chemotherapy in Early Stage NSCLC Patients in Alberta, Canada Marcy Winget, PhD, Jennifer.

Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung Florian Eichhorn, MD, Hendrik Dienemann, MD,

Receipt of Adjuvant Endometrial Cancer Treatment According to Race NRG Oncology/Gynecologic Oncology Group (GOG) 210 Study Ashley Felix, PhD, MPH Assistant.

Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia Jacob J. Inda, MD, Brian F. Kabat,

Benjamin D. Kozower, MD, MPH, Shubin Sheng, PhD, Sean M

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Presentation transcript:

Lior Z. Braunstein MD 1, Andrzej Niemierko PhD 2, Mina N. Shenouda MD 2, Linh Truong 3, Betro T. Sadek MD 2, Rita Abi Raad MD 2, Julia S. Wong MD 3, Rinaa S. Punglia MD MPH 3, Alphonse G. Taghian MD PhD 2, Jennifer R. Bellon MD 3 1 Harvard Radiation Oncology Program; Depts of Radiation Oncology, 2 Massachusetts General Hospital and 3 Brigham and Women’s Hospital and Dana Farber Cancer Institute Harvard Radiation Oncology Program Outcome following local-regional recurrence in women with early stage breast cancer: Impact of biologic subtype ASTRO Annual Meeting, September 2014 Session (DPD 03) Breast.

Baseline patient cohort. Among LRR, in-breast recurrence was the most common site. Surgery was universally offered for recurrence.

Significant predictors of LRR. Triple negative subtype was the most adverse predictor of DFS following LRR. Size of initial tumor and use of salvage surgery were also associated with DFS.

DFS following LRR by subtype.